UB Paderborn / Katalog / Suche / in CDI

26 – 50 von 741

Sortiert nach

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Endocrine-related cancer, 2023-08, Vol.30 (8), p.1

2023

Volltextzugriff (PDF)

Influence of type‐I Interferon receptor expression level on the response to type‐I Interferons in human pancreatic cancer cells

Journal of cellular and molecular medicine, 2014-03, Vol.18 (3), p.492-502

2014

Volltextzugriff (PDF)

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

Cancers, 2022-09, Vol.14 (18), p.4442

2022

Volltextzugriff (PDF)

Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)

European journal of nuclear medicine and molecular imaging, 2024-03, Vol.51 (4), p.1121-1132

2024

Volltextzugriff (PDF)

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

European journal of endocrinology, 2010-08, Vol.163 (2), p.293

2010

Volltextzugriff (PDF)

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

The journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2452-2462

2004

Volltextzugriff (PDF)

Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells

Neuroendocrinology, 2020-04, Vol.110 (5), p.351-363

2020

Volltextzugriff (PDF)

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Current oncology reports, 2021-04, Vol.23 (4), p.46-46, Article 46

2021

Volltextzugriff (PDF)

Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome

The journal of clinical endocrinology and metabolism, 2024-05, Vol.109 (6), p.e1424-e1433

2024

Volltextzugriff (PDF)

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

The journal of clinical endocrinology and metabolism, 2012-04, Vol.97 (4), p.1303-1310

2012

Volltextzugriff (PDF)

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

Neuroendocrinology, 2010-01, Vol.92 (1), p.111-115

2010

Volltextzugriff (PDF)

Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation

PloS one, 2014-08, Vol.9 (8), p.e104944-e104944

2014

Volltextzugriff (PDF)

Disagreement in normative IGF‐I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiency

Clinical endocrinology (Oxford), 2018-03, Vol.88 (3), p.409-414

2018

Volltextzugriff (PDF)

Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations

PloS one, 2016-03, Vol.11 (3), p.e0150453-e0150453

2016

Volltextzugriff (PDF)

Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells

Frontiers in oncology, 2021-07, Vol.11, p.645732-645732

2021

Volltextzugriff (PDF)

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

The journal of clinical endocrinology and metabolism, 2016-12, Vol.101 (12), p.4574-4584

2016

Volltextzugriff (PDF)

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

Reviews in endocrine & metabolic disorders, 2009-06, Vol.10 (2), p.91-102

2009

Volltextzugriff (PDF)

Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors

Endocrine Connections, 2022-04, Vol.11 (4), p.1-9

2022

Volltextzugriff (PDF)

Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia

Endocrine-related cancer, 2014-08, Vol.21 (4), p.653-661

2014

Volltextzugriff (PDF)

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo

Pharmaceutics, 2022-01, Vol.14 (1), p.173

2022

Volltextzugriff (PDF)

Medical Treatment of Cushing's Disease

The journal of clinical endocrinology and metabolism, 2013-02, Vol.98 (2), p.425-438

2013

Volltextzugriff (PDF)

The Introduction of the IDS-iSYS Total IGF-1 Assay May Have Far-Reaching Consequences for Diagnosis and Treatment of GH Deficiency

The journal of clinical endocrinology and metabolism, 2015-01, Vol.100 (1), p.309-316

2015

Volltextzugriff (PDF)

Efficacy of a dopamine–somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study

Endocrine-related cancer, 2008-06, Vol.15 (2), p.583-596

2008

Volltextzugriff (PDF)

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

Biomedicines, 2022-02, Vol.10 (3), p.517

2022

Volltextzugriff (PDF)

Novel insights in dopamine receptor physiology

European journal of endocrinology, 2007-04, Vol.156 Suppl 1, p.S13

2007

Volltextzugriff (PDF)

26 – 50 von 741

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(678)
Mit Volltextzugriff
(631)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(524)
Life Sciences & Biomedicine
(483)
Humans
(407)
Biological And Medical Sciences
(228)
Female
(213)
Male
(212)
Endocrinology & Metabolism
(211)
Medical Sciences
(194)
Middle Aged
(151)
Adult
(148)
Animals
(128)
Aged
(102)
Oncology
(102)
Fundamental And Applied Biological Sciences. Psychology
(82)
Somatostatin - Analogs & Derivatives
(72)
Endocrinopathies
(70)
Tumors
(67)
Vertebrates: Endocrinology
(58)
Receptors, Somatostatin - Metabolism
(57)
Rats
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Unfavorable biological behavior and treatment response of neuroendocrine ovarian metastases of midgut neuroendocrine tumors

Influence of type‐I Interferon receptor expression level on the response to type‐I Interferons in human pancreatic cancer cells

Preclinical Evaluation of Novel Tyrosine-Kinase Inhibitors in Medullary Thyroid Cancer

Intra-arterial peptide-receptor radionuclide therapy for neuro-endocrine tumour liver metastases: an in-patient randomised controlled trial (LUTIA)

Aberrant expression of multiple hormone receptors in ACTH-independent macronodular adrenal hyperplasia causing Cushing's syndrome

Dopamine Receptor Expression and Function in Corticotroph Pituitary Tumors

Effect of the Tryptophan Hydroxylase Inhibitor Telotristat on Growth and Serotonin Secretion in 2D and 3D Cultured Pancreatic Neuroendocrine Tumor Cells

Strategies Towards Improving Clinical Outcomes of Peptide Receptor Radionuclide Therapy

Epigenetic Mechanisms Modulated by Glucocorticoids With a Focus on Cushing Syndrome

The Hypercoagulable State in Cushing's Disease Is Associated with Increased Levels of Procoagulant Factors and Impaired Fibrinolysis, But Is Not Reversible after Short-Term Biochemical Remission Induced by Medical Therapy

Medical Treatment of Cushing’s Syndrome: Adrenal-Blocking Drugs and Ketaconazole

Inhibin alpha-subunit (INHA) expression in adrenocortical cancer is linked to genetic and epigenetic INHA promoter variation

Disagreement in normative IGF‐I levels may lead to different clinical interpretations and GH dose adjustments in GH deficiency

Potency of Full-Length MGF to Induce Maximal Activation of the IGF-I R Is Similar to Recombinant Human IGF-I at High Equimolar Concentrations

Modifying Effects of Glucose and Insulin/Insulin-Like Growth Factors on Colon Cancer Cells

Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

Aberrant tryptophan metabolism in stromal cells is associated with mesenteric fibrosis in small intestinal neuroendocrine tumors

Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo

Medical Treatment of Cushing's Disease

The Introduction of the IDS-iSYS Total IGF-1 Assay May Have Far-Reaching Consequences for Diagnosis and Treatment of GH Deficiency

Efficacy of a dopamine–somatostatin chimeric molecule, BIM-23A760, in the control of cell growth from primary cultures of human non-functioning pituitary adenomas: a multi-center study

The Class I HDAC Inhibitor Valproic Acid Strongly Potentiates Gemcitabine Efficacy in Pancreatic Cancer by Immune System Activation

Novel insights in dopamine receptor physiology

Suchergebnisse filtern